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Abstract
Background: The methylotrophic yeast, Pichia pastoris, offers the possibility to generate a high amount of
recombinant proteins in a fast and easy way to use expression system. Being a single-celled microorganism, P.
pastoris is easy to manipulate and grows rapidly on inexpensive media at high cell densities. A simple and direct
method for the selection of high-producing clones can dramatically enhance the whole production process along
with significant decrease in production costs.
Results: A visual method for rapid selection of high-producing clones based on mannanase reporter system was
developed. The study explained that it was possible to use mannanase activity as a measure of the expression level
of the protein of interest. High-producing target protein clones were directly selected based on the size of
hydrolysis holes in the selected plate. As an example, the target gene (9elp-hal18) was expressed and purified in
Pichia pastoris using this technology.
Conclusions: A novel methodology is proposed for obtaining the high-producing clones of proteins of interest,
based on the mannanase reporter system. This system may be adapted to other microorganisms, such as
Saccharomyces cerevisiae for the selection of clones.
Background
Recently, the methylotrophic yeast Pichia pastoris is
used for high level production of recombinant proteins
for basic research and medical applications [1-4]. Many
heterologous proteins have been successfully expressed
in Pichia pastoris due to its exceptional natural capacity
for heterologous protein production http://www.kgi.edu/
Faculty-and-Research/James-M-Cregg.html. Escherichia
coli can produce large amounts of heterologous protein,
but due to the difference in protein folding environment
and inability to perform posttranslational modifications,
it fails to deliver correctly folded functional protein.
Whereas Pichia pastoris eukaryotic system has been
used successfully for non-expressible proteins in E. coli
[5]. The main advantage of Pichia over E. coli is to pro-
duce disulfide bonds and glycosylations in proteins; this
means that in cases where disulfides are necessary, E.
coli might produce a misfolded protein that is usually
inactive or insoluble.
Yeasts differ substantially from higher eukaryotes in
post-translational modification, especially in glycosyla-
tion. Saccharomyces cerevisiae glycosylation pattern
usually results in hyperglycosylated inactive proteins
[6,7]. Pichia pastoris strains have been re-engineered to
overcome this undesired glycan modification [5]. Avail-
ability of new strains with mammalian-type glycosylation
capabities has made P. pastoris more important for the
industrial production of therapeutic proteins [8]. Opti-
mization of protein yield, which is primarily determined
by protein expression levels, is a very important cost-
saving area. A good screening and selection method for
high-producing Pichia pastoris clones certainly help to
lower the costs significantly.
The major method to select the high-producing
recombinants in yeast is to use the antibiotic resistance
genes. Mostly yeast expression vectors contain dominant
drug resistance markers which allow enrichment of
strains with multiple copies of foreign gene expression
cassettes. It is deliberated that vectors contains the
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dent resistance to the antibiotic G418 in P. pastoris
transformants [9], whereas some series of vectors which
contains the Sh ble gene confer dose-dependent resis-
tance to the antibiotic Zeocin. Selection of multi-copy
transformants is usually performed, after the primary
selection of transformants on plates, containing different
concentrations of antibiotic. However, there are limita-
t i o n so ft h i sm e t h o da s :( i) the number of colonies
screened by antibiotic is limited to approximately 100,
(ii) T h eh i g h e rv e c t o rc o p yn u m b e rd o e sn o ta l w a y s
result in the higher protein yield, the protein expression
level still needs to be determined. So, additional meth-
ods such as western blot analysis [9] or enzyme-linked
immunosorbent assay (ELISA) [10,11] are in dire need
to determine the expression level of the protein. Conse-
quently, more versatile system are required for rapid
selection of high-producing clones.
In this critique, a novel method for rapid selection of
high-producing clones based on the mannanase activity
reporter system is emphasized. The role of target pro-
tein 9Elp-Hal18 has not been obviously studied in the P.
pastoris.D u r i n gt h es t u d yag e n ee n c o d i n g‘mannanase’
was selected as the reporter gene that was to be
expressed with the gene for target protein 9Elp-Hal18,
linked by short peptides Glu-Lys-Arg-Glu-Ala-Glu-Ala
(EKREAEA) (recognized by the Kex2 and Ste13 pro-
tease) was investigated.
Results
Construction of the recombinant expression vector
pHBM306
The recombinant plasmid pHBM305 was constructed by
reverse PCR. The sequence of short peptides Glu-Lys-
Arg-Glu-Ala-Glu-Ala (EKREAEA) and the restriction
enzyme sites was confirmed by Invitrogen Company.
pHBM306 was constructed by inserting 9elp-hal18 gene
between the Nde I and Not I restriction sites. Flow chart
is given in Figure 1.
Selection of the clones of different sizes for the
mannanase activity analysis
P. pastoris GS115 was transformed with linearized
pHBM306 plasmid DNA and the recombinant transfor-
mants were first selected on minimal selective MD med-
ium. These clones were transferred to the BMMY plates
containing thypan blue which makes the plates look blue
colored. Clear zone can be seen around mannanase
expressing colonies which could hydrolyze the Konjac
Glucomannan (KGM). Different sizes of hydrolysis holes
were observed and measured after 24-48 hours of cultur-
ing (Figure 2). Twenty clones with different sizes of
hydrolysis holes were measured and selected for the fol-
lowing enzyme activity assay. It is observed from the
mannanase activity analysis that clones with larger clear
zone correlate with higher mannanase activity (Figure 3).
Purification, characterization and SDS-PAGE analysis of
fusion protein
For further confirmation, four clones with different dia-
meter of holes for the following mannanase activity
assay and target protein assay were selected. The super-
natant of each fermentation broth was analyzed by
SDS-PAGE after 120 hours of culturing. Results clearly
demonstrate successful separation of the reporter and
target protein with molecular mass evaluation of ~42
kDa and ~40 kDa, respectively (Figure 4) and are well
in consistence with the actual molecular masses. The
target protein was also purified from the supernatant of
fermentation broth by inverse transition cycle (ITC)
procedure. The SDS-PAGE assay results demonstrated
9Elp-Hal18 was successfully purified with good purity
(Figure 5).
Mannanase activity measurement was also executed
for the clones selected in order to determine the quality
of the target protein 9Elp-Hal18 which was purified
from the supernatant of cultures. About 448.5 mg/L of
9Elp-Hal18 with 30 U/ml of mannanase activity(A),
336.7 mg/L of 9Elp-Hal18 with 26 U/ml of mannanase
activity, 275.3 mg/L of 9Elp-Hal18 with 20 U/ml of
mannanase activity (C) and 0.23 mg/L of 9Elp-Hal18
with 1.23 U/ml of mannanase activity (D), respectively
were purified. These results clearly support our hypoth-
esis that larger clear zone corresponds to high produc-
tion of the target protein.
Discussion
The methylotrophic yeast P. pastoris has already been
used successfully for the production of various recombi-
nant heterologous proteins [12,13] and has been
licensed to more than 120 companies in the biotechno-
logical, pharmaceutical, animal health and food indus-
tries http://www.pichia.com. Some of the proteins are
produced at grams per liter levels. Using the P. pastoris
system to express foreign proteins has many advantages:
The techniques needed for molecular genetic manipula-
tion are similar to those well established for S. cerevi-
siae; P. pastoris can be easily grown to high cell
densities using defined minimal media and is able to
introduce eukaryotic posttranslational modifications;
Distribution and chain length of N-linked oligosacchar-
ides are different from those of S. cerevisiae.F o r
instance, the chain length is significantly shorter, making
it an interesting alternative for the extra-cellular expres-
sion of human proteins [14]; Complex proteins such as
human glycoproteins or human collagens are also suc-
cessfully processed and secreted by P. pastoris [15-18];
Another advantage of the P. pastoris expression system
Hu et al. BMC Biotechnology 2011, 11:23
http://www.biomedcentral.com/1472-6750/11/23
Page 2 of 7is the secretion of foreign proteins into culture media
which making it convenient to obtain large amounts of
foreign proteins in a relatively pure form without the
contamination of cellular proteins. With the availability
of new genetically engineered strains that show mam-
malian-type glycosylation, interest in using P. pastoris
for the industrial production of therapeutic proteins has
increased even further. So a good method for the
screening and selection of high-producing transformants
is certainly very useful that will ultimately decrease the
cost of the industrial production.
The concept of a mannanase reporter system is to use
the mannanase activity as a measure of the expression
levels of a protein of interest. This can be achieved by
integrating the reporter gene (mannanase) and the gene
of interest under the same promoter, from where they
can be expressed proportionally. We cloned the fusion
protein expression cassette into the pHBM305 vector,
resulting in pHBM306 expression vector (Figure 1). In
both the pHBM305 and the modified pHBM306 plas-
mids, the HIS4 selection marker was used for selection
of stable integrants based on complementation of P.
pastoris HIS4 mutant strains. For the fusion protein
expression, the AOX1 promoter was used for expression
of the protein of interest [19]. During the protein secre-
tion pathway, the fusion protein was separated by the
cleavage of the kex2 and ste13 protease. Results also
show that the marker protein is separated from the tar-
get protein (Figure 4) and the mannanase activity is pro-
portional to the target protein expression level. The
enzyme activity assay also clearly showed that the bigger
hydrolysis hole is correlated with high activity of clone.
It is concluded that the activity of the mannanase or the
size of hydrolysis hole is a measure of the 9Elp-Hal18
expression because it has a positive correlation with
quantity of the target protein.
Compared with other selection methods, such as using
antibiotics, G418 or Zeocin for selecting the multi-copy
Figure 1 Flow chart of construction of the recombinant Pichia pastoris vector pHBM306.
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advantages in screening high-producing clones. First, it’s
bio-safe and eliminates the need for antibiotics as well
as of enzyme-linked immunosorbent assay and western
blot analysis, which are time-consuming and expensive
techniques. Second, it is a high-throughput selection
method, which can efficiently select thousands of clones
at one time, in contrast with the antibiotic screening,
which is limited to approximately 100 clones at a time.
Third, it can be screened and selected directly by the
clear zones or hydrolysis holes in the plate. The bigger
holes corresponding to high-producing clones. Also this
screening system has potential to give more output [20]
when combined with multi-copy in vivo fusion of the
Figure 2 Different size of hole after 24 hours culture in the
BMMY plate.
Figure 3 Relative activity assay of the fermentation broth
supernatant. All measurements were carried out as triplicates, and
means ± SD are shown. The trend line shows a linear; Curve fitting
was performed by Microsoft Excel 2003.
Figure 4 SDS-PAGE analysis of supernatant of fermentation
broth at each stage. M, molecular weight markers; 1, supernatant
of clone A; 2, supernatant of clone B; 3, supernatant of clone C; 4,
supernatant of clone D (control).
Figure 5 SDS-PAGE analysis of purified 9Elp-Hal18. M, molecular
weight markers; 1, purified the protein 9Elp-Hal18.
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these experiments in our future research work.
When deciding that protein secretion is the preferred
approach to be used for a particular target protein, a
choice of the specific secretion signal must be made
[20]. This selection can be based on the protein’so w n
native secretion signal (if it has one), the S. cerevisiae
alpha -mating factor pre -pro leader sequence (a-MF),
the acid phosphatase signal sequence (PHO) or the
invertase signal sequence (SUC2) [20,21]. The most
commonly used signal sequence in P. pastoris secretion
systems is the S. cerevisiae alpha -mating factor pre
-pro leader sequence. Although the a-MF pre -pro
sequence has been used extensively. There are some
instances where its application has been problematic.
The main reason is due to the insertion of Glu-Ala
dipeptide repeats between the amino-terminus of the
mature recombinant protein and the Kex2p cleavage
site. Although the Glu-Ala repeats do improve the pro-
portion of correctly cleaved material by preventing
steric hindrance of the kex2p cleavage site [20,22].
Their presence results in the generation of a recombi-
nant protein with Glu-Ala amino terminal extensions.
This can lead to N-terminal ragged ends due to differ-
ential amino-terminal processing because of the inabil-
ity of the ste13p to process the large quantity of
recombinant protein that is being produced [20,23]. As
t h ep r e s e n c eo ft h e s ea m i n o - terminal dipeptide exten-
sions is undesirable for many recombinant protein
applications, the Glu-Ala repeats between the mature
protein and the kex2p can be omitted as part of the
cloning approach in order to achieve a more authentic
amino-terminus. Omission of these Glu-Ala repeats,
however, can result in a decreased efficiency in the
Kex2p cleavage specificity. In this case, secretion of the
pro-protein cleavage products that have long amino-
terminal extensions corresponding to 9-11 amino acids
of the a-MF pro-region has been observed [20,24].
T h i sc a nb ea ni s s u ew h e np r oducing biopharmaceuti-
cals. The one possible way to solve this problem is to
treat fermentation broth by adding the purified Kex2
protease in vitro [25].
Conclusions
In heterologous protein production, fast and inexpensive
screening processes are desperately required to reduce
the production cost of recombinant proteins. The Pichia
pastoris products will eventually appear in the market
and the use of this mannanase reporter system is
obviously a valuable substitution method for time con-
suming and expensive selection techniques. The results
clearly demonstrate that this visual method brings about
rapid selection of high-producing clones for expression
of secretary recombinant proteins. Furthermore, such
reporter system can be easily applied to other indust-
rially important yeast expression systems.
Methods
Strains and plasmids
E. coli XL10-GOLD (Stratagene, La Jolla, CA) was used
to construct the recombinant plasmids. P. pastoris
GS115 strain, genotype his4 (Invitrogen, Carlsbad, CA,
USA), was used for yeast transformation and protein
expression. pHBM-man [obtained from our own lab]
was used to construct the expression vector pHB306.
Vector pET-9elp-hal18 constructed in a previous
research work contained the gene for the target protein
(9Elp-Hal18) and Konjac Glucomannan (KGM) was
used as the mannanase hydrolysis substrate.
Construction of expression plasmid
Short peptides Glu-Lys-Arg-Glu-Ala-Glu-Ala and two
restriction sites, Nde I and Not I were added at the ends
of the mannanase gene by reverse PCR. Product of 9elp-
hal18 gene was selected as the target protein to evaluate
the new reporter system. 9elp-hal18 gene was obtained
from the plasmid pET-9elp-hal18 by restriction diges-
tion at the Nde Ia n dNot I sites. These were cloned
between the same restriction sites in the plasmid
pHBM305. This new recombinant plasmid was desig-
nated as pHBM306.
Yeast Transformation
pHBM306 plasmid DNA (10 μg) was linearized by using
Sal I restriction enzyme to delete ampicillin resistance
gene and the origin of E. coli. P. pastoris cells were
transformed with the linearized plasmid DNA by elec-
troporation method according to the protocol given in
Pichia Expression kit manual. Yeast cells were grown in
yeast extract-peptone-glucose (YPD) medium following
the manufacturer’s recommendations. Plasmid
pHBM905 was used to prepare the control strain.
Mannanase Activity Assay of the clones with different
sizes of clear zone
Linearized pHBM306 was transformed into P. pastoris
GS115 and integrated at the P. pastoris HIS4 locus.
Transformants were first selected on minimal selective
MD medium (0.34% YNB, 4×10
-5 % biotin, 1% dextrose,
and 1.5% agar) and then transferred to the BMMY
plates (100 mM potassium phosphate, pH 6.0, 0.34%
YNB, 4×10
-5 % biotin, 0.5% methanol, 1% yeast extract,
2% peptone) containing 1% KGM and 0.02% Thypan
blue. After 24-48 hours, hydrolysis holes of different
sizes could be observed in the culture plates. Twenty
clones with different sizes of hydrolysis holes were mea-
sured and selected for the following enzyme activity
assay.
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directly, twenty clones with different sizes were selected
from BMMY with KGM added and were inoculated in
50 ml BMGY medium (1% glycerol replaced by 0.5%
methanol in BMMY) in a 500 ml shake flask. These cul-
tures were centrifuged when optical density reached 20
(equivalent to 1×10
9 cells/ml), at 600 nm (OD600). The
cell mass was re-suspended to 25 ml BMMY medium to
induce recombinant mannanase expression. These cul-
tures were grown for 120 hours at a temperature of 28°
C while shaking at 250 rpm. Mannanase activity in cul-
ture supernatants was assayed after 120 hours culture. It
was determined by measuring the amount of reducing
sugars liberated during the hydrolysis of KGM by the
dinitrosalicylic acid method [26]. The standard assay
reaction mixture consisted of 3% (w/v) of polysaccharide
substrates supplemented with 50 mM sodium citrate
buffer (pH 6.0) and enzyme to make a final volume of
0.3 ml. The reaction mixture was incubated at 55°C for
15 min because one unit of enzyme produced 1 μmol of
reducing sugar per min.
Purification, characterization and SDS-PAGE analysis of
9Elp-Hal18
Target protein concentration was also measured for the
colonies selected to determine Mannanase activity. Tar-
get protein 9Elp-Hal18 was purified from the superna-
tant of the cultures after 120 hours. Due to the unique
properties of Elp fusion protein, 9Elp-Hal18 can be
easily separated and purified from mannanase and other
contaminating proteins, from the supernatant by inverse
transition cycle (ITC) procedure (a very simple method
for purification of recombinant proteins) [27,28]. Target
protein was purified from the supernatant of fermenta-
tion broth was mixed with protein sample buffer (0.5 M
Tris-HCl [pH 6.8], 10% glycerol, 5% sodium dodecyl sul-
fate [SDS], 5% b-mercaptoethanol, 0.25% bromophenol
blue), heated to 100°C for 5 min and then subjected to
12% (w/v) SDS-polyacrylamide gel electrophoresis (SDS-
PAGE). The protein bands were detected by silver stain-
ing. Protein concentrations were measured using Micro-
BCA Protein Assay Reagent (Pierce, USA).
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